Agency Information Collection Activities; Proposed Collection; Comment Request; Draft Guidance for Tobacco Retailers on Tobacco Retailer Training Programs, 72710-72712 [2011-30327]
Download as PDF
<![CDATA[
72710
Federal Register / Vol. 76, No. 227 / Friday, November 25, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2010–D–0350]
[Docket No. FDA–2011–N–0231]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Adverse Experience Reporting for
Licensed Biological Products; and
General Records
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection provisions of
the draft guidance entitled ‘‘Tobacco
Retailer Training Programs.’’
DATES: Submit written or electronic
comments on the collection of
information by January 24, 2012.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, (301) 796–
5156, daniel.gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995
(PRA)(44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
SUMMARY:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Adverse Experience Reporting for
Licensed Biological Products; and
General Records’’ has been approved by
the Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
SUMMARY:
Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, (301) 796–
7726, ila.mizrachi@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
On July
19, 2011, the Agency submitted a
proposed collection of information
entitled ‘‘Adverse Experience Reporting
for Licensed Biological Products; and
General Records’’ to OMB for review
and clearance under 44 U.S.C. 3507. An
Agency may not conduct or sponsor,
and a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0308. The
approval expires on November 30, 2014.
A copy of the supporting statement for
this information collection is available
on the Internet at https://
www.reginfo.gov/public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
Dated: November 18, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
wreier-aviles on DSK7SPTVN1PROD with NOTICES
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Draft Guidance for
Tobacco Retailers on Tobacco Retailer
Training Programs
[FR Doc. 2011–30326 Filed 11–23–11; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
14:31 Nov 23, 2011
Jkt 226001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, in the Federal Register of
July 16, 2010 (75 FR 41498), FDA
published a notice of availability of the
draft guidance document providing a
60-day public comment period on the
collection of information provisions. An
electronic version of the guidance
document is available on the Internet at
https://www.regulations.gov (Docket No.
FDA–2010–D–0350) and https://
www.fda.gov/TobaccoProducts/
GuidanceComplianceRegulatory
Information/default.htm. FDA received
seven comments in response to the
notice of availability, with four
comments pertaining to the information
collection.
FDA is republishing notice of the
proposed collection of information in
order to comply with section
3506(c)(2)(A) of the PRA. We invite
comments only on the proposed
collection of information set forth in
this document. FDA will respond to
comments on the collection of
information provisions received in
response to this notice and to the July
16, 2010, notice in a 30-day notice
announcing that a proposed collection
of information has been submitted to
OMB for review and clearance under the
PRA.
With respect to the collection of
information associated with the draft
guidance, FDA invites comments on
these topics: (1) Whether the proposed
collection of information is necessary
for the proper performance of FDA’s
functions, including whether the
information will have practical utility;
(2) the accuracy of FDA’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques,
when appropriate, and other forms of
information technology.
Information Request Regarding Draft
Guidance for Tobacco Retailers on
Tobacco Retailer Training Programs
(OMB Control Number 0910–New)
The Tobacco Control Act does not
require retailers to implement retailer
training programs. However, the statute
does provide for lesser civil money
penalties for violations of access,
advertising, and promotion restrictions
of regulations promulgated under
section 906(d) of the Federal Food,
E:\FR\FM\25NON1.SGM
25NON1
72711
Federal Register / Vol. 76, No. 227 / Friday, November 25, 2011 / Notices
Drug, and Cosmetic Act, as amended by
the Tobacco Control Act, for retailers
who have implemented a training
program that complies with standards
developed by the FDA for such
programs. The FDA intends to
promulgate regulations establishing
standards for approved retailer training
programs. In the interim, the draft
guidance is intended to assist tobacco
retailers in implementing effective
training programs for employees.
The draft guidance discusses the
elements that should be covered in a
training program, such as: (1) Federal
laws restricting the access to, and the
advertising and promotion of, cigarettes
and smokeless tobacco products; (2) the
health and economic effects of tobacco
use, especially when the tobacco use
begins at a young age; (3) written
company policies against sales to
minors; (4) identification of the tobacco
products sold in the retail establishment
that are subject to the Federal laws
prohibiting their sale to persons under
the age of 18; and (5) age verification
methods. The draft guidance
recommends that retailers require
current and new employees to take a
written test prior to selling tobacco
products and that refresher training be
provided at least annually and more
frequently as needed. The draft
guidance recommends that retailers
maintain certain written records
documenting that all individual
employees have been trained and that
retailers retain these records for 4 years
in order to be able to provide evidence
of a training program during the 48month time period covered by the civil
money penalty schedules in section
103(q)(2)(A) of the Tobacco Control Act.
The draft guidance also recommends
that retailers implement certain hiring
and management practices as part of an
effective retailer training program. The
draft guidance suggests that applicants
and current employees be notified both
verbally and in writing of the
importance of complying with laws
prohibiting the sales of tobacco products
to persons under the age of 18 and that
they should be required to sign an
acknowledgement stating that they have
read and understand the information. In
addition, FDA recommends that
retailers implement an internal
compliance check program and
document the procedures and corrective
actions for the program.
FDA’s estimate of the number of
respondents in tables 1 and 2 of this
document is based on data reported to
the U.S. Department of Health and
Human Services Substance Abuse and
Mental Health Services Administration
(SAMHSA). According to the fiscal year
2009 Annual Synar Report, there are
372,677 total retail tobacco outlets in
the 50 States, District of Columbia, and
8 U.S. territories that are accessible to
youth (meaning that there is no State
law restricting access to these outlets to
individuals older than age 18). Inflating
this number by about 10 percent to
account for outlets in States that sell
tobacco but are, by law, inaccessible to
minors results in an estimated total
number of tobacco outlets of 410,000.
We assume that 75 percent of tobacco
retailers already have some sort of
training program for age and
identification verification. We expect
that some of those retailer training
programs already meet the elements in
the draft guidance, some retailers would
update their training program to meet
the elements in the draft guidance, and
other retailers would develop a training
program for the first time. Thus, we
estimate that two-thirds of tobacco
retailers would develop a training
program that meets the elements in the
draft guidance (66 percent of 410,000 =
270,600).
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ONE TIME REPORTING BURDEN1
Number of
Respondents
Activity
Annual
frequency
per
response
Total annual
responses
Hours per
response
Total hours
Develop training program ....................................................
Develop written policy against sales to minors & employee
acknowledgment ...............................................................
Develop internal compliance check program ......................
270,600
1
270,600
16
4,329,600
270,600
270,600
1
1
270,600
270,600
1
8
270,600
2,164,800
Total ..............................................................................
........................
........................
........................
........................
6,765,000
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
Recordkeepers
Activity
Annual
frequency per
record-keeping
Total annual
records
Hours per
record
Total hours
270,600
4
1,082,400
.25
270,600
270,600
270,600
4
2
1,082,400
541,200
.10
.5
108,240
270,600
Total ..............................................................................
wreier-aviles on DSK7SPTVN1PROD with NOTICES
Training program ..................................................................
Written policy against sales to minors & employee acknowledgment ..................................................................
Internal compliance check program .....................................
........................
........................
........................
........................
649,440
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Mar<15>2010
14:31 Nov 23, 2011
Jkt 226001
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
E:\FR\FM\25NON1.SGM
25NON1
72712
Federal Register / Vol. 76, No. 227 / Friday, November 25, 2011 / Notices
Dated: November 18, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–30327 Filed 11–23–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0841]
Agency Emergency Processing Under
the Office of Management and Budget
Review; Submission for Office of
Management and Budget Review;
Comment Request; Food and Drug
Administration Food Safety
Modernization Act: Economic Hardship
Fee Reduction Guidance
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA). The proposed collection of
information concerns a guidance
document that outlines the criteria and
the process through which firms may
request a reduction of fees based on
severe economic hardship of the FDA
Food Safety Modernization Act (FSMA)
reinspection and recall user fees that are
mandated by the Federal Food, Drug,
and Cosmetic Act (the FD&C Act).
DATES: Fax written comments on the
collection of information by December
15, 2011. FDA is requesting OMB
approval of this emergency processing
by January 6, 2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
(202) 395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–New and
title ‘‘FDA Food Safety Modernization
Act: Economic Hardship Fee Reduction
Guidance.’’ Also include the FDA
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
wreier-aviles on DSK7SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
14:31 Nov 23, 2011
Jkt 226001
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, (301) 796–
3793.
SUPPLEMENTARY INFORMATION: FDA has
requested emergency processing of this
proposed collection of information
under section 3507(j) of the PRA (44
U.S.C. 3507(j) and 5 CFR 1320.13). FDA
requests permission to use the
emergency clearance procedures to
obtain OMB approval of the information
collection related to the economic
hardship fee reduction guidance. FDA
expects to use a print-and-mail or an
email form for fee reduction requests. If
FDA were to use the normal clearance
procedures, the approval of the
information collection would not be
finalized in time to issue invoices in
January 2012. FDA seeks OMB approval
of the information collection by January
6, 2012, so the Agency can issue such
guidance no later than January 2012.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and
(4) ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
FDA Food Safety Modernization Act:
Economic Hardship Fee Reduction
Guidance (OMB Control Number 0910–
NEW)
On January 4, 2011, the President
signed into law FSMA (Pub. L. 111–
353). Section 743 of the FD&C Act (21
U.S.C. 379j–31) amended by FSMA,
requires FDA to consider the burden of
fee amounts on small businesses.
Section 743(b)(2)(B)(iii) of FD&C Act
states, ‘‘* * *the Secretary shall publish
in the Federal Register a proposed set
of guidelines in consideration of the
burden of fee amounts on small
business. Such consideration may
include reduced fee amounts for small
businesses.* * *’’ Before publishing such
guidelines, FDA believes it is important
to gather additional information related
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
to small business burdens associated
with fees to set forth criteria and a
rational for such criteria for when a user
fee reduction is appropriate. Therefore,
FDA published a document in the
Federal Register of August 1, 2011 (76
FR 45818) (FRN) to seek public
comments and information to assist the
Agency to develop such guidelines.
FDA will review the comments
(comment period closes on November
30, 2011) and then develop the
proposed set of guidelines; these will
likely be implemented in fiscal year
(FY) 2013. However, FDA recognizes
that, meanwhile, for some small
businesses the reinspection or the recall
user fees, which went into effect on
October 1, 2011, could impose severe
economic hardship and there may be
unique circumstances in which some
relief would be appropriate. During FY
2012, FDA will consider waiving some
or all of an invoiced fee based on a
severe economic hardship. FDA intends
to protect businesses and preserve free
competitive enterprise.
FDA is currently developing a
guidance to outline the criteria and the
process through which firms may
request a reduction of fees based on
economic hardship. FDA wants to
consider the public comments from the
small business FRN before finalizing
such guidance. Also, in the recent
‘‘Guidance for Industry: Implementation
of the Fee Provisions of Section 107 of
the FDA Food Safety Modernization
Act’’ that published in the Federal
Register of October 6, 2011 (76 FR
62073), FDA stated that it would ‘‘not
intend to issue invoices for reinspection
or recall order fees until this guidance
document has been finalized.’’
Therefore, FDA needs to publish such
guidance soon after November 30, 2011,
in order to: (1) Issue invoices and
(2) provide important information for
qualified firms to apply for fee
reductions, which will help them to
sustain their businesses. Given such a
short timeframe, use of the normal
clearance process to obtain OMB
approval under the PRA for the
information collection related to the
economic hardship fee reduction
guidance is likely to cause delay of
publishing such guidance and
subsequently cause delay of issuing
invoices. The fees, required by FSMA,
are to cover 100 percent of the costs of
certain reinspection and recall order
activities conducted by FDA.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 76, Number 227 (Friday, November 25, 2011)]
[Notices]
[Pages 72710-72712]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30327]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-D-0350]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Draft Guidance for Tobacco Retailers on Tobacco
Retailer Training Programs
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the information collection provisions of
the draft guidance entitled ``Tobacco Retailer Training Programs.''
DATES: Submit written or electronic comments on the collection of
information by January 24, 2012.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. Identify comments with the docket number found in
brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, (301) 796-5156,
daniel.gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA)(44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. ``Collection of information'' is
defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency
requests or requirements that members of the public submit reports,
keep records, or provide information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in the Federal Register concerning
each proposed collection of information before submitting the
collection to OMB for approval. To comply with this requirement, in the
Federal Register of July 16, 2010 (75 FR 41498), FDA published a notice
of availability of the draft guidance document providing a 60-day
public comment period on the collection of information provisions. An
electronic version of the guidance document is available on the
Internet at https://www.regulations.gov (Docket No. FDA-2010-D-0350) and
https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/default.htm. FDA received seven
comments in response to the notice of availability, with four comments
pertaining to the information collection.
FDA is republishing notice of the proposed collection of
information in order to comply with section 3506(c)(2)(A) of the PRA.
We invite comments only on the proposed collection of information set
forth in this document. FDA will respond to comments on the collection
of information provisions received in response to this notice and to
the July 16, 2010, notice in a 30-day notice announcing that a proposed
collection of information has been submitted to OMB for review and
clearance under the PRA.
With respect to the collection of information associated with the
draft guidance, FDA invites comments on these topics: (1) Whether the
proposed collection of information is necessary for the proper
performance of FDA's functions, including whether the information will
have practical utility; (2) the accuracy of FDA's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) ways to enhance
the quality, utility, and clarity of the information to be collected;
and (4) ways to minimize the burden of the collection of information on
respondents, including through the use of automated collection
techniques, when appropriate, and other forms of information
technology.
Information Request Regarding Draft Guidance for Tobacco Retailers on
Tobacco Retailer Training Programs (OMB Control Number 0910-New)
The Tobacco Control Act does not require retailers to implement
retailer training programs. However, the statute does provide for
lesser civil money penalties for violations of access, advertising, and
promotion restrictions of regulations promulgated under section 906(d)
of the Federal Food,
[[Page 72711]]
Drug, and Cosmetic Act, as amended by the Tobacco Control Act, for
retailers who have implemented a training program that complies with
standards developed by the FDA for such programs. The FDA intends to
promulgate regulations establishing standards for approved retailer
training programs. In the interim, the draft guidance is intended to
assist tobacco retailers in implementing effective training programs
for employees.
The draft guidance discusses the elements that should be covered in
a training program, such as: (1) Federal laws restricting the access
to, and the advertising and promotion of, cigarettes and smokeless
tobacco products; (2) the health and economic effects of tobacco use,
especially when the tobacco use begins at a young age; (3) written
company policies against sales to minors; (4) identification of the
tobacco products sold in the retail establishment that are subject to
the Federal laws prohibiting their sale to persons under the age of 18;
and (5) age verification methods. The draft guidance recommends that
retailers require current and new employees to take a written test
prior to selling tobacco products and that refresher training be
provided at least annually and more frequently as needed. The draft
guidance recommends that retailers maintain certain written records
documenting that all individual employees have been trained and that
retailers retain these records for 4 years in order to be able to
provide evidence of a training program during the 48-month time period
covered by the civil money penalty schedules in section 103(q)(2)(A) of
the Tobacco Control Act.
The draft guidance also recommends that retailers implement certain
hiring and management practices as part of an effective retailer
training program. The draft guidance suggests that applicants and
current employees be notified both verbally and in writing of the
importance of complying with laws prohibiting the sales of tobacco
products to persons under the age of 18 and that they should be
required to sign an acknowledgement stating that they have read and
understand the information. In addition, FDA recommends that retailers
implement an internal compliance check program and document the
procedures and corrective actions for the program.
FDA's estimate of the number of respondents in tables 1 and 2 of
this document is based on data reported to the U.S. Department of
Health and Human Services Substance Abuse and Mental Health Services
Administration (SAMHSA). According to the fiscal year 2009 Annual Synar
Report, there are 372,677 total retail tobacco outlets in the 50
States, District of Columbia, and 8 U.S. territories that are
accessible to youth (meaning that there is no State law restricting
access to these outlets to individuals older than age 18). Inflating
this number by about 10 percent to account for outlets in States that
sell tobacco but are, by law, inaccessible to minors results in an
estimated total number of tobacco outlets of 410,000. We assume that 75
percent of tobacco retailers already have some sort of training program
for age and identification verification. We expect that some of those
retailer training programs already meet the elements in the draft
guidance, some retailers would update their training program to meet
the elements in the draft guidance, and other retailers would develop a
training program for the first time. Thus, we estimate that two-thirds
of tobacco retailers would develop a training program that meets the
elements in the draft guidance (66 percent of 410,000 = 270,600).
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated One Time Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
Annual
Activity Number of frequency per Total annual Hours per Total hours
Respondents response responses response
----------------------------------------------------------------------------------------------------------------
Develop training program........ 270,600 1 270,600 16 4,329,600
Develop written policy against 270,600 1 270,600 1 270,600
sales to minors & employee
acknowledgment.................
Develop internal compliance 270,600 1 270,600 8 2,164,800
check program..................
----------------------------------------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 6,765,000
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Annual
Activity Record- frequency per Total annual Hours per Total hours
keepers record-keeping records record
----------------------------------------------------------------------------------------------------------------
Training program................ 270,600 4 1,082,400 .25 270,600
Written policy against sales to 270,600 4 1,082,400 .10 108,240
minors & employee
acknowledgment.................
Internal compliance check 270,600 2 541,200 .5 270,600
program........................
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 649,440
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
[[Page 72712]]
Dated: November 18, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-30327 Filed 11-23-11; 8:45 am]
BILLING CODE 4160-01-P
